Pedinol Pharmacal Inc

pedinol.com

For over 80 years, PEDiNOL has been a privately held, specialty pharmaceutical company focused on meeting the needs of podiatrists and their patients. Our mission is to serve podiatrists by delivering high quality products supported by attentive customer service.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

FIRST GENE THERAPY CLINICAL TRIAL TO ADDRESS GENETIC BLINDNESS

PharmaNewsIntelligence | March 11, 2020

news image

Oregon Health & Science University (OHSU) held the first-ever gene therapy clinical trial, BRILLIANCE, to address blindness-causing gene mutation, LCA10, according to a recent press release The clinical trial, sponsored by Allergan plc and Editas Medicine, is one of 14 different clinical trials investigating new genetic treatments for ophthalmic conditions and nearly 50 vision-related clinical trials. The procedure uses gene-editing tool CRISPR to edit human genes, also known as in vivo gene...

Read More

PHARMACY MARKET

IAMA THERAPEUTICS ANNOUNCES INITIATION OF PRECLINICAL DEVELOPMENT STUDIES IN DRUG-RESISTANT EPILEPSY UNDER A SERVICE AGREEMENT WITH PSYCHOGENICS

IAMA Therapeutics | July 26, 2022

news image

IAMA Therapeutics, a preclinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel medicines to make a difference in the lives of individuals suffering from brain disorders, and PsychoGenics Inc., a leader in AI-enabled phenotypic drug discovery and preclinical CRO services, today announced that the companies have entered into a service agreement to identify the efficacy of novel drug candidates in drug-resistant epilepsy. Under the...

Read More

APHA: TRANSPARENCY, SAFETY AND AVAILABILITY MUST BE CORE PRINCIPLES FOR STRENGTHENING AMERICA'S DRUG SUPPLY CHAIN

APhA | August 11, 2020

news image

The reliability, quality and safety of our nation's drug supply chain are essential to the nation's security and health and well-being of the American public. Therefore, we welcome comprehensive federal efforts to improve the state of our drug supply chain, particularly at a time when our health care system is under extraordinary stress. The President's Executive Order last week, "Ensuring Essential Medicines, Medical Countermeasures and Critical Inputs Are Made in the United St...

Read More

BUSINESS INSIGHTS

FGC HEALTH EXPANDS SOLUTIONS OFFERINGS WITH ACQUISITION OF PHARMACY ACCESS SOLUTIONS INC (PASI)

FGC Health | March 04, 2022

news image

FGC Health, a national leader in consumer health services, industry-specific business tools and provider of an industry-leading proprietary open-source platform, announced today it has acquired Pharmacy Access Solutions Inc. (PASI), an industry leader in the development of real-time, smart technology solutions in support of automated patient-centric programs and professional service modules, as well as financial and performance reporting for independent owners and banner groups. PASI will contin...

Read More
news image

FIRST GENE THERAPY CLINICAL TRIAL TO ADDRESS GENETIC BLINDNESS

PharmaNewsIntelligence | March 11, 2020

Oregon Health & Science University (OHSU) held the first-ever gene therapy clinical trial, BRILLIANCE, to address blindness-causing gene mutation, LCA10, according to a recent press release The clinical trial, sponsored by Allergan plc and Editas Medicine, is one of 14 different clinical trials investigating new genetic treatments for ophthalmic conditions and nearly 50 vision-related clinical trials. The procedure uses gene-editing tool CRISPR to edit human genes, also known as in vivo gene...

Read More
news image

PHARMACY MARKET

IAMA THERAPEUTICS ANNOUNCES INITIATION OF PRECLINICAL DEVELOPMENT STUDIES IN DRUG-RESISTANT EPILEPSY UNDER A SERVICE AGREEMENT WITH PSYCHOGENICS

IAMA Therapeutics | July 26, 2022

IAMA Therapeutics, a preclinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel medicines to make a difference in the lives of individuals suffering from brain disorders, and PsychoGenics Inc., a leader in AI-enabled phenotypic drug discovery and preclinical CRO services, today announced that the companies have entered into a service agreement to identify the efficacy of novel drug candidates in drug-resistant epilepsy. Under the...

Read More
news image

APHA: TRANSPARENCY, SAFETY AND AVAILABILITY MUST BE CORE PRINCIPLES FOR STRENGTHENING AMERICA'S DRUG SUPPLY CHAIN

APhA | August 11, 2020

The reliability, quality and safety of our nation's drug supply chain are essential to the nation's security and health and well-being of the American public. Therefore, we welcome comprehensive federal efforts to improve the state of our drug supply chain, particularly at a time when our health care system is under extraordinary stress. The President's Executive Order last week, "Ensuring Essential Medicines, Medical Countermeasures and Critical Inputs Are Made in the United St...

Read More
news image

BUSINESS INSIGHTS

FGC HEALTH EXPANDS SOLUTIONS OFFERINGS WITH ACQUISITION OF PHARMACY ACCESS SOLUTIONS INC (PASI)

FGC Health | March 04, 2022

FGC Health, a national leader in consumer health services, industry-specific business tools and provider of an industry-leading proprietary open-source platform, announced today it has acquired Pharmacy Access Solutions Inc. (PASI), an industry leader in the development of real-time, smart technology solutions in support of automated patient-centric programs and professional service modules, as well as financial and performance reporting for independent owners and banner groups. PASI will contin...

Read More